Raising investment funds in the time of COVID
3D robotics supply chain company Attabotics raises $50 million USD in venture capital during a pandemic. Read more.
Further $2.1 million for COVID-19 research
Alberta Innovates is pleased to announce an additional $2.1 M investment in research and innovation projects that will slow the spread and lessen the impact of COVID-19.
Alberta Innovates again invests in COVID-19 rapid response
In partnership with the Canadian Institutes of Health Research, we’re pleased to announce the results of a second partnered investment to stop the spread and lessen the impact of COVID-19.
The Hackathon is now complete. Please see the list of winners. Thank you to everyone that participated.
COVID-19 rapid response funding opportunity
We’ve committed an initial $100,000 to support Alberta-led projects through this funding opportunity.
Alberta-led research to address the most challenging problems for COVID-19
We’ve partnered with the Canadian Institutes of Health Research to commit $4.2 million to Alberta researchers
HOPE COVID-19 Study of HCQ
May 25, 2020 – Out of an abundance of caution for the safety of study participants, the University of Calgary has temporarily suspended enrollment into the Alberta HOPE COVID-19 trial looking into the effectiveness of hydroxychloroquine (HCQ) as an early intervention for COVID-19 until results from a WHO study and others that are ongoing can be reviewed. Follow-up and monitoring of patients enrolled in the trial will continue. We’ll keep you informed, posting updates as we receive more information.